Connect to share and comment

Telephone counseling works for breast cancer-gene tests

By Andrew M. Seaman NEW YORK (Reuters Health) - The counseling that goes along with testing for breast cancer risk genes can be delivered just as effectively over the phone as in person, and at lower cost, according to new research. Researchers found that women counseled over the phone before testing fared about the same in their understanding of the test and reactions to it as those counseled in person.

Alnylam drug found effective in treating rare genetic disease

(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein that causes a rare organ-damaging hereditary disorder. Alnylam shares rose 14 percent to $42.80 in premarket trade. The study was testing a subcutaneously administered version of the drug, ALN-TTR, to treat genetic disorder amyloidosis, which is caused by deposits of protein in tissues and organs.

UK tries out new model for gene testing in cancer patients

By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people.
Syndicate content